$CNTX another Cancer small bio play with a BIG catalyst next month Phase 2 data to be presented at ASCO June 4, 2022 (Onapristone (ONA-XR) Ovarian cancer. Stock is trading nearly 70% below CASH It has a history of Big rallies b4 presentations.
4
4 Likes